Table 3 sTWEAK, NLR, CIMT results according to eGFR groups of renal transplant patients and healthy subjects
From: Soluble TWEAK independently predicts atherosclerosis in renal transplant patients
Parameters | Healthy subjects (n=25) Median (IQR) | eGFR group 1 (n=23) Median (IQR) | eGFR group 2 (n=24) Median (IQR) | eGFR group 3 (n=23) Median (IQR) | p* |
|---|---|---|---|---|---|
MDRD (mL/min) | 107 (52.7) | 83 (13.56) | 63 (8.7) | 42 (22) | <0.0001 |
hs-CRP (mg/L) | 3.3 (2.25-5.8) | 8.7 (5.6-12.6) | 9.45 (4.92-14) | 9.0 (3.3-18) | <0.0001 |
NLR | 1.16 (0.54) | 2.25 (1) | 2.16 (1.5) | 2.58 (2.5) | 0.005 |
CIMT (mm) | 0.4 (0.1) | 0.7 (0.4) | 0.6 (0.4) | 0.7 (0.5) | <0.001 |
sTWEAK (pg/mL) | 457 (320.5-537.8) | 399.5 (329–439) | 382.9 (308.6-421.5) | 361.2 (323.4-426.5) | 0.04 |